Krsnaa Diagnostics Limited · NSE:KRSNAA
Krsnaa Diagnostics — 9M FY2022 Earnings Presentation
32 slides from Krsnaa Diagnostics's earnings presentation, Feb 2, 2022
Slide 1: Q3FY2022 Earnings Presentation cover letter
0 Krs a D I A G N O S T I C S® ...t LET'S DO GOOD...<1< Date: 02 nd February, 2022 BSE Ltd. The National Stock Exchange of India Ltd. Corporate Service Department Exchange Plaza, 3 rd Floor, pt Floor, P.J. Towers, Plot No. C/1, 'G' Block, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai Mumbai
Slide 2: 9M FY2022 Earnings Presentation
One of INDIA’S LARGEST Differentiated Diagnostic 9M FY2022 Earnings Presentation Service Provider www.krsnaadiagnostics.com
Slide 3: Business Overview
Business Overview 2
Slide 4: Krsnaa Diagnostics at a Glance
Krsnaa Diagnostics at a Glance Fastest growing and differentiated diagnostic service provider in India 2011 Aug-21 1,900+ 14 States 29 Million Incorporated Listing at BSE Diagnostics Presence in India Patients Served and NSE Centre Since Inception Krsnaa Diagnostics is one of the fastest growing and
Slide 5: Krsnaa Competitive Advantages
Krsnaa Competitive Advantages Sustainable business model backed by underlying competitive advantages and well positioned to drive growth Revenue Visibility 1 ▪ Long-term of contracts (between 5-10 years) with inbuilt price escalation mechanism ensures higher and consistent visibility of revenues ▪ G
Slide 6: PPP Diagnostics Centres – Best in Class Infrastructure
PPP Diagnostics Centres – Best in Class Infrastructure Developing world class diagnostics infrastructure at the centres and becoming preferred partner under PPP (Actual images of Krsnaa Diagnostics Centre inside Government hospitals) Reception Waiting Area Best in Class Machines and Infrastructure O
Slide 7: Krsnaa Diagnostics Edge
Krsnaa Diagnostics Edge One of the Fastest Extensive Strong Brand Scalable and Disruptive Pricing Stakeholder Value Growing Geographic Equity Agile Business Creation Diagnostic Footprint Model Service Provider in the country ₹ Total Centre count Centres across India Well positioned to PPP is an asse
Slide 8: Fastest Growing Diagnostic Chain In India
Fastest Growing Diagnostic Chain In India Fastest growing diagnostic chain in India, offering high quality services at disruptive prices Started operating 12 Pan India Expansion centres in Himachal Expansion Successful Pradesh in public Centres – 1,300+ Listing on the Centres – 664 private partnersh
Slide 9: Extensive Footprint and Infrastructure
Extensive Footprint and Infrastructure Radiology Centres Pathology Labs 130 Centres 46 CT Scans and MRI Processing Labs 1,303 491 Tele-Reporting Centres Collection Centres 1,433 537 Radiology Centres Pathology Centres As of Dec 2021 8
Slide 10: Leading Radiology and Pathology Diagnostic Service Provider
Leading Radiology and Pathology Diagnostic Service Provider 1,365 Radiology Labs 465 Pathology Labs 1,394 Tests on Offer 2,544 Tests on Offer Served 3.06 mn Customers in FY21 Served 2.10 mn Customers in FY21 4,79,000+ 1,45,000+ 2.4+ mn 5.4 mn 0.9 mn CT Scans MRI Scans X-Rays Non-Covid Tests Conducte
Slide 11: Public Private Partnership – Industry Dynamics
Public Private Partnership – Industry Dynamics Diagnostic industry is underpenetrated in rural areas. Higher Government spend and initiatives is expected to drive PPP model faster than the overall diagnostic industry PPP Model is Backed by Government Initiatives Government Hospitals invite open bids
Slide 12: Public Private Partnership Model Poised to Grow
Public Private Partnership Model Poised to Grow Krsnaa Diagnostic is the Partner for Public Health Agencies Track Record of Faster Expansion and Penetration in India ▪ 1,905 dedicated centres under PPP Model across 14 states ▪ 1,797 dedicated centres under PPP Model across 13 states Centers ▪▪ Scala
Slide 13: Partnership with Private Hospitals
Partnership with Private Hospitals Strategic Tie-ups with Private Health Players Private Centres Drives Brand Visibility and Brand Recall Centers ▪ Krsnaa Diagnostic is selectively entering into strategic tie-ups with leading Private Health Players 19% ▪ 26 centres under Private Model across 2 state
Slide 14: India’s Largest Tele-Radiology Reporting Hub
India’s Largest Tele-Radiology Reporting Hub Krsnaa Diagnostics hub and spoke model radiology facility in Pune is fully capable to process large volumes ▪ Scalable business model and enables wider penetration into tier II and tier III cities Patient Report delivered to Entry ▪ Analog images gets con
Slide 15: High Quality Diagnostic Services at Disruptive Prices
High Quality Diagnostic Services at Disruptive Prices Krsnaa offers radiology tests at 45%-60% lower and pathology tests at 40%-80% lower than market rates % from min Segment Test Player 1 Player 2 Player 3 Krsnaa price RDL CT Brain 4,500 4,500 3,500 2,000 (43%) “Krsnaa Diagnostics offers high quali
Slide 16: Defined Strategy to Deliver Sustainable Long Term Growth
Defined Strategy to Deliver Sustainable Long Term Growth Continue to Expand Presence Expand Diagnostic Services with Disciplined Acquisition to Expand across India Focus on Specialized Diagnostics Geographical Footprint Expand network within India, particularly in Pursue selective acquisitions and s
Slide 17: Recent Developments
Recent Developments 16
Slide 18: Projects Won
Projects Won Krsnaa Diagnostics won 5 PPP and private contracts to commission 29 CT Scanners and 8 MRI machines Punjab Radiology contract Himachal Pradesh Radiology contract 1 ▪ Punjab Government will allocate vacant space to establish 2 ▪ Hospitals in Solan and Bilaspur will provide for vacant spac
Slide 19: PPP Projects – Quality Infrastructure and Brand Visibility
PPP Projects – Quality Infrastructure and Brand Visibility High quality infrastructure and services at disruptive prices creates market awareness and drives direct walk-ins Branding at Centres World Class Infrastructure Krsnaa Logo on all Reports Krsnaa Diagnostics – Brand Awareness and Market Visib
Slide 20: PPP Projects – Implementation on Track
PPP Projects – Implementation on Track Punjab MCGM - Mumbai Radiology Radiology Operationalized Operationalized Operationalized Total To be Operationalized in Total To be Operationalized in in in in Centres February and March 2022 Centres February and March 2022 December 2021 January 2022 January 20
Slide 21: New Centres Operationalized
New Centres Operationalized Affordable, Accessible and Best in class Services Best in Class Infrastructure and Qualified Staff Strong Support from All Stakeholders Note: New Centre inaugurated at Bhabha Hospital, Kurla by Senior Citizens in the presence of hospital administration 20
Slide 22: 9M FY2022 Performance Update
9M FY2022 Performance Update 21
Slide 23: 9M FY2022 Performance Highlights
9M FY2022 Performance Highlights Krsnaa delivers stellar performance with Revenues of Rs. 347 Cr and EBITDA* of Rs. 105 Cr & margins of 30.2% in 9M FY22 In 9M FY22, Krsnaa surpasses FY21 numbers in terms of EBITDA and Profit Before Tax with strong improvement in margins Core Business of Radiology an
Slide 24: 9M FY2022 Performance Highlights
9M FY2022 Performance Highlights Revenue up by 16%, EBITDA1 up by 73% and PAT2 is up by 215% Core business drives strong growth while Covid-19 contribution continues to decline ▪ Revenues up by 16%, primarily driven by growth in core business i.e Radiology and EBITDA and Margins Pathology which regi
Slide 25: Management Perspective
Management Perspective Commenting on the results, Mr. Yash Mutha, Executive Director, said: “In 9MFY22, Krsnaa Diagnostics has delivered strong performance with revenues of Rs. 347 crore, an increase of 16% y-o-y. The growth was underpinned by Core Businesses which grew by 85% and partially offset b
Slide 26: Revenue and Segment Mix
Revenue and Segment Mix Revenue from Operations 16% Y-o-Y Revenue from Operations Breakdown (In Rs. Mn) 394 3,472 (71)% 3,005 1,243 1,345 96% 633 1,083 1,065 50 13 979 1,835 191 423 409 79% 316 1,028 610 643 472 Q3FY21 Q2FY22 Q3FY22 9MFY21 9MFY22 Q3FY21 Q2FY22 Q3FY22 9MFY21 9MFY22 Radiology Patholog
Slide 27: Profitability and Margins
Profitability and Margins (In Rs. Mn) Gross Profits and Margins 49% Y-o-Y EBITDA and Margins* 73% Y-o-Y 1,049 2,164 1,451 606 673 673 324 304 526 62.3% 62.1% 63.2% 48.3% 205 30.2% 53.7% 29.9% 28.6% 20.2% 21.0% Q3FY21 Q2FY22 Q3FY22 9MFY21 9MFY22 Q3FY21 Q2FY22 Q3FY22 9MFY21 9MFY22 Profit Before Tax**
Slide 28: Operational Performance Trend
Operational Performance Trend Core Business i.e Radiology and Pathology saw an increase in both, Number of Tests and Average Revenue Per Test in 9MFY22 Decline in average revenue per patient and per test in 9M FY22 is due to significant decline in the prices of Covid-19 tests Number of Patient (in M
Slide 29: Financial Performance
Financial Performance Q3 Y-o-Y Q2 Q-o-Q Nine Months Y-o-Y Particulars (in Mn) FY2022 FY2021 Growth (%) FY2022 Growth (%) FY2022 FY2021 Growth (%) Core Business Revenues 1,052 788 33.6% 1,033 1.8% 3,078 1,661 85.3% Covid-19 Revenues 13 191 (93.3)% 50 (74.3)% 394 1,345 (70.7)% Revenue from Operations
Slide 30: Annual Performance Trend
Annual Performance Trend (In Rs. Mn) Revenue from Operations 64% CAGR Gross Profits and Margins 42% CAGR 2,045 2,164 3,965 3,472 1,552 2,584 1,296 2,092 721 61.9% 62.3% 60.0% 906 51.6% 79.6% FY18 FY19 FY20 FY21 9MFY22 FY18 FY19 FY20 FY21 9MFY22 Revenue from EBITDA* Operations and Margins 48% CAGR Pr
Slide 31: Contact Information
Contact Information This presentation contains statements that are “forward looking statements” including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements relating to Krsnaa Diagnostics’ future business developments and economic perfor
Slide 32: Contact us: Krsnaa Diagnostics Ltd.
Contact us: Krsnaa Diagnostics Ltd. S.No.243,A-Hissa No.6/6 CTS No.4519, Near Mayur Trade Centre, Chinchwad, Pune, India - 411 019